Open Access

Collapsin response mediator protein 4 enhances the radiosensitivity of colon cancer cells through calcium‑mediated cell signaling

  • Authors:
    • Sang Yoon Park
    • Jong-Tae Kim
    • Eun Sun Park
    • Yo Sep Hwang
    • Hyang Ran Yoon
    • Kyoung Eun Baek
    • Haiyoung Jung
    • Suk Ran Yoon
    • Bo Yeon Kim
    • Hee Jun Cho
    • Hee Gu Lee
  • View Affiliations

  • Published online on: January 29, 2021     https://doi.org/10.3892/or.2021.7957
  • Article Number: 6
  • Copyright: © Park et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Radiation therapy is an effective treatment against various types of cancer, but some radiation‑resistant cancer cells remain a major therapeutic obstacle; thus, understanding radiation resistance mechanisms is essential for cancer treatment. In this study, we established radiation‑resistant colon cancer cell lines and examined the radiation‑induced genetic changes associated with radiation resistance. Using RNA‑sequencing analysis, collapsin response mediator protein 4 (CRMP4) was identified as the candidate gene associated with radiation sensitivity. When cells were exposed to radiation, intracellular Ca2+ influx, collapse of mitochondrial membrane potential, and cytochrome c release into the cytosol were increased, followed by apoptosis induction. Radiation treatment‑ or Ca2+ ionophore A23187‑induced apoptosis was significantly inhibited in CRMP4‑deficient cells, including radiation‑resistant or CRMP4‑shRNA cell lines. Furthermore, treatment of CRMP4‑deficient cells with low levels (<5 µM) of BAPTA‑AM, a Ca2+ chelator, resulted in radiation resistance. Conversely, Ca2+ deficiency induced by a high BAPTA‑AM concentration (>10 µM) resulted in higher cell death in the CRMP4‑depleted cells compared to CRMP4‑expressing control cells. Our results suggest that CRMP4 plays an important role in Ca2+‑mediated cell death pathways under radiation exposure and that CRMP4 may be a therapeutical target for colon cancer treatment.
View Figures
View References

Related Articles

Journal Cover

April-2021
Volume 45 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Park SY, Kim J, Park ES, Hwang YS, Yoon HR, Baek KE, Jung H, Yoon SR, Kim BY, Cho HJ, Cho HJ, et al: Collapsin response mediator protein 4 enhances the radiosensitivity of colon cancer cells through calcium‑mediated cell signaling. Oncol Rep 45: 6, 2021
APA
Park, S.Y., Kim, J., Park, E.S., Hwang, Y.S., Yoon, H.R., Baek, K.E. ... Lee, H.G. (2021). Collapsin response mediator protein 4 enhances the radiosensitivity of colon cancer cells through calcium‑mediated cell signaling. Oncology Reports, 45, 6. https://doi.org/10.3892/or.2021.7957
MLA
Park, S. Y., Kim, J., Park, E. S., Hwang, Y. S., Yoon, H. R., Baek, K. E., Jung, H., Yoon, S. R., Kim, B. Y., Cho, H. J., Lee, H. G."Collapsin response mediator protein 4 enhances the radiosensitivity of colon cancer cells through calcium‑mediated cell signaling". Oncology Reports 45.4 (2021): 6.
Chicago
Park, S. Y., Kim, J., Park, E. S., Hwang, Y. S., Yoon, H. R., Baek, K. E., Jung, H., Yoon, S. R., Kim, B. Y., Cho, H. J., Lee, H. G."Collapsin response mediator protein 4 enhances the radiosensitivity of colon cancer cells through calcium‑mediated cell signaling". Oncology Reports 45, no. 4 (2021): 6. https://doi.org/10.3892/or.2021.7957